Idarucizumab-facilitated intravenous thrombolysis in acute ischemic stroke: A therapeutic strategy requiring further investigation
Journal
Journal of the Neurological Sciences
Journal Volume
394
Pages
144-145
Date Issued
2018
Author(s)
Subjects
Dabigatran; Hemorrhagic transformation; Idarucizumab; Ischemic stroke; Thrombolysis
SDGs
Other Subjects
dabigatran; idarucizumab; idarucizumab; monoclonal antibody; anticoagulation; artificial embolization; blood clot lysis; brain hemorrhage; brain ischemia; clinical effectiveness; clinical practice; clinical trial (topic); disease severity; drug effect; drug safety; evidence based practice; hemorrhagic transformation; human; laboratory test; Letter; low risk patient; outcome assessment; percutaneous thrombectomy; phase 3 clinical trial (topic); priority journal; risk assessment; risk factor; stroke patient; treatment indication; brain ischemia; cerebrovascular accident; complication; fibrinolytic therapy; immunology; procedures; Antibodies, Monoclonal, Humanized; Brain Ischemia; Clinical Trials as Topic; Dabigatran; Humans; Stroke; Thrombolytic Therapy
Type
letter